Real-world use of multigene signatures in early breast cancer: differences to clinical trials
Article in Breast Cancer Research and Treatment (January 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy
Article in British Journal of Cancer (November 2023)
Real-world use of multigene signatures in early breast cancer: differences to clinical trials
Preprint in Research Square (September 2023)